Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J. Kuter, Janet L. Nichol, David H. Henry et al.|The Lancet|2008Cited by 862
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITPJames B. Bussel, Janet L. Nichol, David J. Kuter et al.|New England Journal of Medicine|2006Cited by 530
Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccinationEun‐Ju Lee, James B. Bussel|American Journal of Hematology|2021Cited by 387
Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 PatientsAndromachi Scaradavou, James B. Bussel, Bonnie Woo et al.|Blood|1997Cited by 318
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodiesLouis M. Aledort, James B. Bussel, Catherine P.M. Hayward et al.|American Journal of Hematology|2004Cited by 194